Why Tekton?
Proven outcomes across trials and teams.
At Tekton, we believe the best measure of success is real-world impact. That’s why we let the results speak for themselves. Below, you’ll find a selection of case studies that showcase how our work drives measurable outcomes for sponsors, patients, and partners.
Targets surpassed
Tekton exceeded enrollment targets across all 3 sites in a Type 1 Diabetes trial, with our McKinney, TX site more than doubling its goal—prompting the sponsor to spotlight our team as a model for best practices.
Rapid Enrollment, Record Results
Tekton delivered 172% average enrollment across 7 sites, for a total of >720 patients for a 2024 Global Phase 3 vaccine clinical trial.
Accelerated Enrollment
Tekton Research sites averaged just 1 day from activation to first patient visit for a phase 3 norovirus vaccine trial, with 3 of 7 sites achieving this milestone in under 24 hours.
Setting the Pace: First Patient In
Tekton Research led the way in an Alzheimer’s Disease trial by enrolling the study’s first patient, surpassing enrollment goals and contributing to protocol design.
